Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

China, Japan, S. Korea In Pact To Cooperate In Flu Outbreaks

This article was originally published in PharmAsia News

Executive Summary

China, Japan and South Korea have signed a plan to cooperate with each other in case an influenza pandemic occurs. Each of the three nations is to establish an agency responsible for communicating with the other two and sharing information if there is an outbreak of flu, including bird flu. Chen Zhu, China's health minister, said the three nations have a lot of movement of personnel and commercial exchanges among them, increasing the risk of flu infection. (Click here for more

You may also be interested in...



Flu Pandemic Represents Single Biggest Threat To Business Continuity - Harvard Business Review

HONG KONG - National protectionism, unwillingness to share information and limited supplies of vaccines and antiviral products could hamper efforts to tackle an influenza pandemic, according to experts at a symposium in Hong Kong Dec. 1

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Latest Headlines
See All
UsernamePublicRestriction

Register

SC067278

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel